Christopher Ogden

Entity
Individual
Business address
C/O Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, 94080 South San Francisco, CA
Signature Ownership
/s/ Christopher Ogden
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Christopher Ogden has filed 14 SEC EDGAR filings since 3/9/2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing Sep 30, 2025 Sep 26, 2025 001-37587
4 Open Document Open Filing Jun 17, 2025 Jun 13, 2025 001-37587
4 Open Document Open Filing Mar 20, 2025 Mar 18, 2025 001-37587
4 Open Document Open Filing Feb 6, 2025 Feb 4, 2025 001-37587
4 Open Document Open Filing Aug 22, 2024 Aug 20, 2024 001-37587
4 Open Document Open Filing Jun 14, 2024 Jun 12, 2024 001-37587
4 Open Document Open Filing Mar 21, 2024 Mar 19, 2024 001-37587
4 Open Document Open Filing Jan 19, 2024 Jan 18, 2024 001-37587
4 Open Document Open Filing Dec 22, 2023 Dec 20, 2023 001-37587
4 Open Document Open Filing Dec 19, 2023 Dec 17, 2023 001-37587
4 Open Document Open Filing Mar 20, 2023 Mar 16, 2023 001-37587
4 Open Document Open Filing FORM 4 Feb 6, 2023 Feb 2, 2023 001-37587
4 Open Document Open Filing FORM 4 Aug 12, 2022 Aug 10, 2022 001-37587
3 Open Document Open Filing FORM 3 Mar 9, 2022 Feb 14, 2022 001-37587